Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Drug Discovery Informatics Market by Region & Data Validation, Analysis and Forecast 2022

Tuesday, February 21, 2017 10:59
% of readers think this story is Fact. Add your two cents.

(Before It's News)

According to Publisher, the Global Drug Discovery Informatics Market is accounted for $1.91 billion in 2015 and is expected to reach $6.94 billion by 2022 growing at a CAGR of 17.5% from 2015 to 2022. The rising demand for computational technology is the primary factor favouring the market growth. Furthermore, Drug discovery industry and rising number of technologically advanced products are the key drivers for the Drug Discovery Informatics market. However, Lack of information technology and critical attributes of data evaluation are limiting the market growth. The recent trends in Drug Discovery Informatics are considerable shift observed from traditional in-vitro drug development to computer aided drug designing, as costly failures of late drug development increases the use of in-silico models for early ADME/Toxicity screening.
Sequence analysis platforms services accounted the largest revenue share and are expected to continue and dominate the market over the forecast period. North America commanded the largest share driven by the increasing demand for computational technology. However, Asia Pacific is projected to register the fastest growth over the forecast period owing to technological developments in the software and drug nano technology fields carried out in the developing economies.

 For more information http://www.reportsweb.com/drug-discovery-informatics-global-market-outlook-2015-2022

Some of the key players in the market include ChemAxon, GVK Biosciences, Jubilant Biosys, Selvita, Certara, Infosys, Albany Molecular Research Inc., BoehringerIngelheim GmBh,, DiscoverX, Charles River Laboratories, Covance, Collaborative Drug Discovery Inc., Novo Informatics, UCB and Evotec.

Modes Covered:

- In-house Informatics
- Outsourced Informatics
Services Covered:
- Molecular Modelling
- Sequence Analysis Platforms
- Docking
- Clinical Trial Data Management
- Other Services

Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK 
- Spain 
- Rest of Europe 
- Asia Pacific
- Japan 
- China 
- India 
- Australia 
- New Zealand 
- Rest of Asia Pacific 
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt

Request Sample Copy http://www.reportsweb.com/inquiry&RW0001216331/sample 

9 Company Profiling 
9.1 ChemAxon 
9.2 GVK Biosciences 
9.3 Jubilant Biosys 
9.4 Selvita 
9.5 Certara 
9.6 Infosys 
9.7 Albany Molecular Research Inc. 
9.8 BoehringerIngelheimGmBh 
9.9 DiscoverX 
9.10 Charles River Laboratories 
9.11 Covance 
9.12 Collaborative Drug Discovery Inc. 
9.13 Novo Informatics. 
9.14 UCB 
9.15 Evotec 

Make an enquiry: http://www.reportsweb.com/inquiry&RW0001216331/buying

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.